NCBI Summary
SIGLECs are members of the immunoglobulin superfamily that are expressed on the cell surface. Most SIGLECs have 1 or more cytoplasmic immune receptor tyrosine-based inhibitory motifs, or ITIMs. SIGLECs are typically expressed on cells of the innate immune system, with the exception of the B-cell expressed SIGLEC6 (MIM 604405).[supplied by OMIM, Jul 2002].
Protein
Protein (NP_149121)
SIGLEC-10
Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2)
SIGLEC10
sialic acid binding Ig like lectin 10
Undefined
Curated
I-type lectin
I-Type Lectins - CD33-related Siglecs
b-sandwich / Ig-like
NeuAc / Neu5Ac(a2-6)Gal(b1-4)GlcNAc
0.516
MLLPLLLSSLLGGSQAMDGRFWIRVQESVMVPEGLCISVPCSFSYPRQDWTGSTPAYGYWFKAVTETTKGAPVATNHQSREVEMSTRGRFQLTGDPAKGNCSLVIRDAQMQDESQYFFRVERGSYVRYNFMNDGFFLKVTALTQKPDVYIPETLEPGQPVTVICVFNWAFEECPPPSFSWTGAALSSQGTKPTTSHFSVLSFTPRPQDHNTDLTCHVDFSRKGVSAQRTVRLRVAYAPRDLVISISRDNTPALEPQPQGNVPYLEAQKGQFLRLLCAADSQPPATLSWVLQNRVLSSSHPWGPRPLGLELPGVKAGDSGRYTCRAENRLGSQQRALDLSVQYPPENLRVMVSQANRTVLENLGNGTSLPVLEGQSLCLVCVTHSSPPARLSWTQRGQVLSPSQPSDPGVLELPRVQVEHEGEFTCHARHPLGSQHVSLSLSVHYSPKLLGPSCSWEAEGLHCSCSSQASPAPSLRWWLGEELLEGNSSQDSFEVTPSSAGPWANSSLSLHGGLSSGLRLRCEAWNVHGAQSGSILQLPDKKGLISTAFSNGAFLGIGITALLFLCLALIIMKILPKRRTQTETPRPRFSRHSTILDYINVVPTAGPLAQKRNQKATPNSPRTPLPPGAPSPESKKNQKKQYQLPSFPEPKSSTQAPESQESQEELHYATLNFPGVRPRPEARMPKGTQADYAEVKFQ
No structure currently available in the PDB RCSB Databank.
Structural models
SWISS-MODEL structural models
The location of the lectin domain structural model is: 18-146
We infer [1.26, 1.53] Å as the interval of error of this structural model.
Template 1: 2N7B chain: A, Q9NYZ4, NP_055257.2, sequence identity: 48.8%, coverage: 94.6%, location in sequence: 26-152, (10-136 in PDB).
Template 2: 2ZG1 chain: A, O15389, NP_003821.1, sequence identity: 47.3%, coverage: 94.6%, location in sequence: 20-141, (25-146 in PDB).
Template 3: 6D4A chain: B, P20138, NP_001763.3, sequence identity: 45.0%, coverage: 96.1%, location in sequence: 18-141, (18-141 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
We infer [1.26, 1.53] Å as the interval of error of this structural model.
Template 1: 2N7B chain: A, Q9NYZ4, NP_055257.2, sequence identity: 48.8%, coverage: 94.6%, location in sequence: 26-152, (10-136 in PDB).
Template 2: 2ZG1 chain: A, O15389, NP_003821.1, sequence identity: 47.3%, coverage: 94.6%, location in sequence: 20-141, (25-146 in PDB).
Template 3: 6D4A chain: B, P20138, NP_001763.3, sequence identity: 45.0%, coverage: 96.1%, location in sequence: 18-141, (18-141 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
Oligomerization and Known Interactions
Interacts with PTPN6/SHP-1 upon phosphorylation (PubMed:12163025). Interacts with NCF1 (By similarity). Interacts with CD24; the probable CD24:SIGLEC10 complex is proposed to inhibit HGMB1-mediated tissue damage immune response. Interacts with HMGB1; the interaction is dependent on CD24 (PubMed:19264983). Interacts with RIGI, CBL and PTPN11 (By similarity)
Annotation
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
- Novel insights into the function of CD24: A driving force in cancer. [32790899]
- Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins. [32915505]
- Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10. [32765491]
- Siglec-10 expression is up-regulated in activated human CD4+ T cells. [32046870]
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. [31367043]
- Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns. [17672918]
- Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1. [12163025]
- Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. [11358961]
- Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants. [11409878]
- Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. [11284738]
UniProt Main References (6 PubMed Identifiers)
- The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. [12975309]
- Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
- The DNA sequence and biology of human chromosome 19. [15057824]
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
- CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. [19264983]
- Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. [25450598]
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_033130.5)
sialic acid binding Ig like lectin 10, transcript variant 1
m7G-5')ppp(5'-ACUCACAGCACGACCAGAGAACAGGCCUGUCUCAGGCAGGCCCUGCGCCUCCUAUGCGGAGAUGCUACUGCCACUGCUGCUGUCCUCGCUGCUGGGCGGGUCCCAGGCUAUGGAUGGGAGAUUCUGGAUACGAGUGCAGGAGUCAGUGAUGGUGCCGGAGGGCCUGUGCAUCUCUGUGCCCUGCUCUUUCUCCUACCCCCGACAGGACUGGACAGGGUCUACCCCAGCUUAUGGCUACUGGUUCAAAGCAGUGACUGAGACAACCAAGGGUGCUCCUGUGGCCACAAACCACCAGAGUCGAGAGGUGGAAAUGAGCACCCGGGGCCGAUUCCAGCUCACUGGGGAUCCCGCCAAGGGGAACUGCUCCUUGGUGAUCAGAGACGCGCAGAUGCAGGAUGAGUCACAGUACUUCUUUCGGGUGGAGAGAGGAAGCUAUGUGAGAUAUAAUUUCAUGAACGAUGGGUUCUUUCUAAAAGUAACAGCCCUGACUCAGAAGCCUGAUGUCUACAUCCCCGAGACCCUGGAGCCCGGGCAGCCGGUGACGGUCAUCUGUGUGUUUAACUGGGCCUUUGAGGAAUGUCCACCCCCUUCUUUCUCCUGGACGGGGGCUGCCCUCUCCUCCCAAGGAACCAAACCAACGACCUCCCACUUCUCAGUGCUCAGCUUCACGCCCAGACCCCAGGACCACAACACCGACCUCACCUGCCAUGUGGACUUCUCCAGAAAGGGUGUGAGCGCACAGAGGACCGUCCGACUCCGUGUGGCCUAUGCCCCCAGAGACCUUGUUAUCAGCAUUUCACGUGACAACACGCCAGCCCUGGAGCCCCAGCCCCAGGGAAAUGUCCCAUACCUGGAAGCCCAAAAAGGCCAGUUCCUGCGGCUCCUCUGUGCUGCUGACAGCCAGCCCCCUGCCACACUGAGCUGGGUCCUGCAGAACAGAGUCCUCUCCUCGUCCCAUCCCUGGGGCCCUAGACCCCUGGGGCUGGAGCUGCCCGGGGUGAAGGCUGGGGAUUCAGGGCGCUACACCUGCCGAGCGGAGAACAGGCUUGGCUCCCAGCAGCGAGCCCUGGACCUCUCUGUGCAGUAUCCUCCAGAGAACCUGAGAGUGAUGGUUUCCCAAGCAAACAGGACAGUCCUGGAAAACCUUGGGAACGGCACGUCUCUCCCAGUACUGGAGGGCCAAAGCCUGUGCCUGGUCUGUGUCACACACAGCAGCCCCCCAGCCAGGCUGAGCUGGACCCAGAGGGGACAGGUUCUGAGCCCCUCCCAGCCCUCAGACCCCGGGGUCCUGGAGCUGCCUCGGGUUCAAGUGGAGCACGAAGGAGAGUUCACCUGCCACGCUCGGCACCCACUGGGCUCCCAGCACGUCUCUCUCAGCCUCUCCGUGCACUACUCCCCGAAGCUGCUGGGCCCCUCCUGCUCCUGGGAGGCUGAGGGUCUGCACUGCAGCUGCUCCUCCCAGGCCAGCCCGGCCCCCUCUCUGCGCUGGUGGCUUGGGGAGGAGCUGCUGGAGGGGAACAGCAGCCAGGACUCCUUCGAGGUCACCCCCAGCUCAGCCGGGCCCUGGGCCAACAGCUCCCUGAGCCUCCAUGGAGGGCUCAGCUCCGGCCUCAGGCUCCGCUGUGAGGCCUGGAACGUCCAUGGGGCCCAGAGUGGAUCCAUCCUGCAGCUGCCAGAUAAGAAGGGACUCAUCUCAACGGCAUUCUCCAACGGAGCGUUUCUGGGAAUCGGCAUCACGGCUCUUCUUUUCCUCUGCCUGGCCCUGAUCAUCAUGAAGAUUCUACCGAAGAGACGGACUCAGACAGAAACCCCGAGGCCCAGGUUCUCCCGGCACAGCACGAUCCUGGAUUACAUCAAUGUGGUCCCGACGGCUGGCCCCCUGGCUCAGAAGCGGAAUCAGAAAGCCACACCAAACAGUCCUCGGACCCCUCUUCCACCAGGUGCUCCCUCCCCAGAAUCAAAGAAGAACCAGAAAAAGCAGUAUCAGUUGCCCAGUUUCCCAGAACCCAAAUCAUCCACUCAAGCCCCAGAAUCCCAGGAGAGCCAAGAGGAGCUCCAUUAUGCCACGCUCAACUUCCCAGGCGUCAGACCCAGGCCUGAGGCCCGGAUGCCCAAGGGCACCCAGGCGGAUUAUGCAGAAGUCAAGUUCCAAUGAGGGUCUCUUAGGCUUUAGGACUGGGACUUCGGCUAGGGAGGAAGGUAGAGUAAGAGGUUGAAGAUAACAGAGUGCAAAGUUUCCUUCUCUCCCUCUCUCUCUCUCUUUCUCUCUCUCUCUCUCUUUCUCUCUCUUUUAAAAAAACAUCUGGCCAGGGCACAGUGGCUCACGCCUGUAAUCCCAGCACUUUGGGAGGUUGAGGUGGGCAGAUCGCCUGAGGUCGGGAGUUCGAGACCAGCCUGGCCAACUUGGUGAAACCCCGUCUCUACUAAAAAUACAAAAAUUAGCUGGGCAUGGUGGCAGGCGCCUGUAAUCCUACCUACUUGGGAAGCUGAGGCAGGAGAAUCACUUGAACCUGGGAGACGGAGGUUGCAGUGAGCCAAGAUCACACCAUUGCACGCCAGCCUGGGCAACAAAGCGAGACUCCAUCUCAAAAAAAAAAUCCUCCAAAUGGGUUGGGUGUCUGUAAUCCCAGCACUUUGGGAGGCUAAGGUGGGUGGAUUGCUUGAGCCCAGGAGUUCGAGACCAGCCUGGGCAACAUGGUGAAACCCCAUCUCUACAAAAAAUACAAAACAUAGCUGGGCUUGGUGGUGUGUGCCUGUAGUCCCAGCUGUCAGACAUUUAAACCAGAGCAACUCCAUCUGGAAUAGGAGCUGAAUAAAAUGAGGCUGAGACCUACUGGGCUGCAUUCUCAGACAGUGGAGGCAUUCUAAGUCACAGGAUGAGACAGGAGGUCCGUACAAGAUACAGGUCAUAAAGACUUUGCUGAUAAAACAGAUUGCAGUAAAGAAGCCAACCAAAUCCCACCAAAACCAAGUUGGCCACGAGAGUGACCUCUGGUCGUCCUCACUGCUACACUCCUGACAGCACCAUGACAGUUUACAAAUGCCAUGGCAACAUCAGGAAGUUACCCGAUAUGUCCCAAAAGGGGGAGGAAUGAAUAAUCCACCCCUUGUUUAGCAAAUAAGCAAGAAAUAACCAUAAAAGUGGGCAACCAGCAGCUCUAGGCGCUGCUCUUGUCUAUGGAGUAGCCAUUCUUUUGUUCCUUUACUUUCUUAAUAAACUUGCUUUCACCUUAC-3'- Poly-A tail - Coding region
DNA
DNA (Gene ID: 89790)
sialic acid binding Ig like lectin 10
strand -
SIGLEC-10, SLG2, PRO940, MGC126774
NCBI CDS gene sequence (2094 bp)
5'-ATGCTACTGCCACTGCTGCTGTCCTCGCTGCTGGGCGGGTCCCAGGCTATGGATGGGAGATTCTGGATACGAGTGCAGGAGTCAGTGATGGTGCCGGAGGGCCTGTGCATCTCTGTGCCCTGCTCTTTCTCCTACCCCCGACAGGACTGGACAGGGTCTACCCCAGCTTATGGCTACTGGTTCAAAGCAGTGACTGAGACAACCAAGGGTGCTCCTGTGGCCACAAACCACCAGAGTCGAGAGGTGGAAATGAGCACCCGGGGCCGATTCCAGCTCACTGGGGATCCCGCCAAGGGGAACTGCTCCTTGGTGATCAGAGACGCGCAGATGCAGGATGAGTCACAGTACTTCTTTCGGGTGGAGAGAGGAAGCTATGTGAGATATAATTTCATGAACGATGGGTTCTTTCTAAAAGTAACAGCCCTGACTCAGAAGCCTGATGTCTACATCCCCGAGACCCTGGAGCCCGGGCAGCCGGTGACGGTCATCTGTGTGTTTAACTGGGCCTTTGAGGAATGTCCACCCCCTTCTTTCTCCTGGACGGGGGCTGCCCTCTCCTCCCAAGGAACCAAACCAACGACCTCCCACTTCTCAGTGCTCAGCTTCACGCCCAGACCCCAGGACCACAACACCGACCTCACCTGCCATGTGGACTTCTCCAGAAAGGGTGTGAGCGCACAGAGGACCGTCCGACTCCGTGTGGCCTATGCCCCCAGAGACCTTGTTATCAGCATTTCACGTGACAACACGCCAGCCCTGGAGCCCCAGCCCCAGGGAAATGTCCCATACCTGGAAGCCCAAAAAGGCCAGTTCCTGCGGCTCCTCTGTGCTGCTGACAGCCAGCCCCCTGCCACACTGAGCTGGGTCCTGCAGAACAGAGTCCTCTCCTCGTCCCATCCCTGGGGCCCTAGACCCCTGGGGCTGGAGCTGCCCGGGGTGAAGGCTGGGGATTCAGGGCGCTACACCTGCCGAGCGGAGAACAGGCTTGGCTCCCAGCAGCGAGCCCTGGACCTCTCTGTGCAGTATCCTCCAGAGAACCTGAGAGTGATGGTTTCCCAAGCAAACAGGACAGTCCTGGAAAACCTTGGGAACGGCACGTCTCTCCCAGTACTGGAGGGCCAAAGCCTGTGCCTGGTCTGTGTCACACACAGCAGCCCCCCAGCCAGGCTGAGCTGGACCCAGAGGGGACAGGTTCTGAGCCCCTCCCAGCCCTCAGACCCCGGGGTCCTGGAGCTGCCTCGGGTTCAAGTGGAGCACGAAGGAGAGTTCACCTGCCACGCTCGGCACCCACTGGGCTCCCAGCACGTCTCTCTCAGCCTCTCCGTGCACTACTCCCCGAAGCTGCTGGGCCCCTCCTGCTCCTGGGAGGCTGAGGGTCTGCACTGCAGCTGCTCCTCCCAGGCCAGCCCGGCCCCCTCTCTGCGCTGGTGGCTTGGGGAGGAGCTGCTGGAGGGGAACAGCAGCCAGGACTCCTTCGAGGTCACCCCCAGCTCAGCCGGGCCCTGGGCCAACAGCTCCCTGAGCCTCCATGGAGGGCTCAGCTCCGGCCTCAGGCTCCGCTGTGAGGCCTGGAACGTCCATGGGGCCCAGAGTGGATCCATCCTGCAGCTGCCAGATAAGAAGGGACTCATCTCAACGGCATTCTCCAACGGAGCGTTTCTGGGAATCGGCATCACGGCTCTTCTTTTCCTCTGCCTGGCCCTGATCATCATGAAGATTCTACCGAAGAGACGGACTCAGACAGAAACCCCGAGGCCCAGGTTCTCCCGGCACAGCACGATCCTGGATTACATCAATGTGGTCCCGACGGCTGGCCCCCTGGCTCAGAAGCGGAATCAGAAAGCCACACCAAACAGTCCTCGGACCCCTCTTCCACCAGGTGCTCCCTCCCCAGAATCAAAGAAGAACCAGAAAAAGCAGTATCAGTTGCCCAGTTTCCCAGAACCCAAATCATCCACTCAAGCCCCAGAATCCCAGGAGAGCCAAGAGGAGCTCCATTATGCCACGCTCAACTTCCCAGGCGTCAGACCCAGGCCTGAGGCCCGGATGCCCAAGGGCACCCAGGCGGATTATGCAGAAGTCAAGTTCCAATGA-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.